Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carsten Boess currently holds 20,000 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carsten Boess has been a net seller of KNSA stock. They have purchased $117.8K and sold $17.9M worth of shares.
Carsten Boess's most recent insider trade was on Feb 27, 2026, when they sold 20,000 shares at $0.00 per share.
Carsten Boess serves as Executive at Kiniksa Pharmaceuticals, Ltd. (KNSA). They have executed 156 insider transactions totaling $18.0M over their tenure at the company.
Carsten Boess holds the position of Executive at Kiniksa Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Carsten Boess has shown a selling trading pattern, with $117.8K in total purchases and $17.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carsten Boess was on Oct 30, 2014, when they sold $1.8M worth of GEVA shares. This transaction involved 22,904 shares at $80.11 per share.
Carsten Boess currently owns 20,000 shares of Kiniksa Pharmaceuticals, Ltd. (KNSA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carsten Boess's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carsten Boess has 156 Form 4 filings on record as an insider at Kiniksa Pharmaceuticals, Ltd..
Set alerts for Carsten Boess and 40,000+ other insiders.